Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.

SEOUL, May 24 (Reuters) - South Korean biosimilars maker

Samsung Bioepis Co Ltd said on Tuesday it has applied to the

U.S. Food and Drug Administration (FDA) for approval to sell its

version of...

Read more